Cases of prostate cancer in California Spike

Cases of prostate cancer are increasing in California, according to new research.

A study by UC San Francisco (UCSF) included nearly 388,000 men who had prostate cancer between 2004 and 2021.

The incidence rate of cases increased 6.7% per year on average between 2011 and 2021, the research published by Jama.

Although the cases increased, the level of prostate cancer mortality fell 2.6% a year from 2004 to 2012, and collapsed from 2012 to 2021.

These tendencies were similar in all age, race, ethnicity and the region, researchers discovered.

Increasing cases correspond to a change in PSA testing guidelines (prostate -specified antigen), in which the US preventive service task force prohibited the recommendation of performances in 2012, according to UCSF press release.

The instructions were changed to reduce the number of patients with prostate cancer, who were treated with “potentially harmful interference” for non -threatening forms of the disease.

According to UCSF, prostate cancer is the most common cancer in men and the second leading cause of cancer deaths.

However, most prostate cancer tumors are low-rate and “never spread”-and PSA examination does not distinguish between aggressive or non-aggressive tumors, making many men diagnose with cancers that will not They damaged them in the long run, ”the release said.

“On the other hand, if the examination is not done, the timely diagnosis of more advanced cancers may be lost – those cancers may have been successfully treated if they are early,” noted UCSF.

Freezing in shows “unfortunately may have led to one of the biggest subsequent rise in the incidence of distant phase disease”, according to researchers.

UCSF wrote that these findings “strengthen the need for consideration that can identify potentially fatal tumors without raising false alerts for those that poser any threat to the patient”.

“To discover the best way to control prostate cancer continues to be a challenge for researchers and doctors,” said the author of the main study Dr. Erin L. Van Blagra, Associate Professor of Epidemiology, Biostatics and Urology, UCSF, in a statement.

“Without examination, the number of men diagnosed with advanced prostate cancer – when treatments are less effective – increases quickly.”

Senior Medical Analyst Fox News Marc Siegel, who was not involved in the study, also called the need for regular appearances.

“[Screenings] It sat in many areas, including California, as the US preventive service task recommended against the SAP as a regular review tool I have not always agreed with, “he told Fox News Digital.” Especially after MRI progressed, so that not all PSA raised automatically meant a biopsy. “

Based on increased cases of prostate cancer at all ages, Siegel emphasized the need to “diagnose it early for better results”.

Siegel suggested that increasing cases may also be due to a variety of factors, including overweight epidemic, ultraprochive foods and an increase in alcohol consumption and fatty foods.

David R. Wise, MD, PhD, Urologic Oncologist and Chief of the Genitourinary Medical Oncology Program Service at the NYU Languone Perlmutter Cancer Center also reacted to this increase in cases.

“Increased incidence of prostate metastatic cancer in California in 2010 is in line with reports from others, including American Cancer Society,” Wise, which was not involved in the research, said Fox News Digital.

“It is likely to reflect the consequences of reduced examination of prostate cancer. A return to the examination of prostate cancer is likely to return this effect. “

“Optimized review, improved by MRI and young blood -based biomarkers, is now available and is ready to save men with low risk of unnecessary treatment providing early detection for men with aggressive cancer,” he added.

Khloe Quill I Fox News Digital contributed to reporting.